C
Cellumed Co Ltd
KOSDAQ:049180
Cellumed Co Ltd
KOSDAQ:049180
Price:
1 150
KRW
-0.86%
Market Closed
Market Cap:
₩95.6B
Relative Value
The Relative Value of one Cellumed Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 1 150 KRW, Cellumed Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Cellumed Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Cellumed Co Ltd Competitors
Cellumed Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Cellumed Co Ltd
KOSDAQ:049180
|
95.6B KRW | 0.6 | -4.5 | -14.3 | -12.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.8B USD | 4.4 | 29.6 | 17 | 23.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.9B USD | 17.1 | 60.2 | 45.7 | 56.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
139.8B USD | 5.5 | 42.3 | 21.5 | 26 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
116.7B USD | 3.3 | 25.2 | 13.8 | 20.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 5.2 | 36 | 21.1 | 28.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
44.7B EUR | 1.9 | 21.2 | 11.7 | 16.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.5B USD | 11 | 44.9 | 31.9 | 35.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 7.8 | 44.1 | 24.2 | 26.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48B USD | 2.1 | 26.3 | 10.3 | 17.4 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD | 6.7 | 24.2 | 17.1 | 19 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
